Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Affitech AS
Affitech raises NOK 86 million in private placement
May 8th, 2006
The human antibody company Affitech AS has raised a further NOK 86 million in a new private placement. The company will use the cash to carry out preclinical development of its several in-house discovered oncology antibody therapeutic candidates and to accelerate selection of some of the candidates for clinical studies. Affitech discovered the antibody candidates by using the company's proprietary CBAS (Cell Based Antibody Selection) technology. The participants in the financing round included existing investors, Teknoinvest, Ferd Venture. Four Seasons Venture, and Braganza AS, along with a major new investment from Arendals Fossekompani. Martin...
Source: Biotech Week (2006-05-08)
|
